Renaissance Capital logo

BRNS News

US IPO Weekly Recap: UFC owner Endeavor Group leads a 7 IPO week

FRF

The IPO market stayed active this past week with seven IPOs raising $1.9 billion. One company withdrew ahead of its expected pricing, specialty insurer The Fortegra Group (FRF). SPAC activity picked up slightly, with three blank check IPOs...read more

UK biotech Vaccitech prices US IPO at $17 midpoint

Barinthus Biotherapeutics (Vaccitech) logo

Vaccitech, which develops T cell immunotherapies and vaccines for cancers, COVID-19, and other diseases, raised $111 million by offering 6.5 million ADSs at $17, within the range of $16 to $18. Vaccitech is a clinical-stage biopharmaceutical company engaged...read more

UK biotech Vaccitech sets terms for $111 million US IPO; co-developer of AstraZeneca COVID-19 vaccine

Barinthus Biotherapeutics (Vaccitech) logo

Vaccitech, which develops T cell immunotherapies and vaccines for cancers, COVID-19, and other diseases, announced terms for its IPO on Monday. The Oxford, United Kingdom-based company plans to raise $111 million by offering 6.5 million ADSs at a price...read more

US IPO Week Ahead: April closes out with a diverse 7 IPO week

AVAH

Updated Monday, 4/26. With the end of April on the horizon, seven IPOs are currently slated to raise $2.2 billion in the week ahead. The diverse group features a home care provider, a talent agency, and more. Home care provider ...read more